Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Return on Capital Employed (2021 - 2025)

Biofrontera has reported Return on Capital Employed over the past 5 years, most recently at 1.12% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 1.12% for Q4 2025, up 95.0% from a year ago — trailing twelve months through Dec 2025 was 1.12% (up 95.0% YoY), and the annual figure for FY2025 was 0.84%, up 48.0%.
  • Return on Capital Employed for Q4 2025 was 1.12% at Biofrontera, up from 3.37% in the prior quarter.
  • Over the last five years, Return on Capital Employed for BFRIW hit a ceiling of 12.33% in Q2 2025 and a floor of 3.37% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 1.23% (2021), compared with a mean of 0.51%.
  • Peak annual rise in Return on Capital Employed hit 1371bps in 2025, while the deepest fall reached -122bps in 2025.
  • Biofrontera's Return on Capital Employed stood at 1.23% in 2021, then soared by 53bps to 0.58% in 2022, then plummeted by -203bps to 1.75% in 2023, then decreased by -18bps to 2.08% in 2024, then soared by 46bps to 1.12% in 2025.
  • The last three reported values for Return on Capital Employed were 1.12% (Q4 2025), 3.37% (Q3 2025), and 12.33% (Q2 2025) per Business Quant data.